Structural basis for HIV-1 neutralization by a gp41 fusion intermediate-directed antibody

Nat Struct Mol Biol. 2006 Aug;13(8):740-7. doi: 10.1038/nsmb1127. Epub 2006 Jul 23.

Abstract

Elicitation of potent and broadly neutralizing antibodies is an important goal in designing an effective human immunodeficiency virus-1 (HIV-1) vaccine. The HIV-1 gp41 inner-core trimer represents a functionally and structurally conserved target for therapeutics. Here we report the 2.0-A-resolution crystal structure of the complex between the antigen-binding fragment of D5, an HIV-1 cross-neutralizing antibody, and 5-helix, a gp41 inner-core mimetic. Both binding and neutralization depend on residues in the D5 CDR H2 loop protruding into the conserved gp41 hydrophobic pocket, as well as a large pocket in D5 surrounding core gp41 residues. Kinetic analysis of D5 mutants with perturbed D5-gp41 interactions suggests that D5 persistence at the fusion intermediate is crucial for neutralization. Thus, our data validate the gp41 N-peptide trimer fusion intermediate as a target for neutralizing antibodies and provide a template for identification of more potent and broadly neutralizing molecules.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / chemistry*
  • Antibodies, Monoclonal / metabolism
  • Cells, Cultured
  • Crystallography, X-Ray
  • HIV Envelope Protein gp41 / chemistry*
  • HIV Envelope Protein gp41 / immunology*
  • HIV Envelope Protein gp41 / metabolism
  • HIV-1 / immunology*
  • HIV-1 / metabolism
  • Humans
  • Hydrophobic and Hydrophilic Interactions
  • Leucine / chemistry
  • Models, Molecular
  • Mutation
  • Neutralization Tests
  • Protein Conformation
  • Recombinant Fusion Proteins / chemistry
  • Recombinant Fusion Proteins / genetics
  • Recombinant Fusion Proteins / metabolism
  • Tryptophan / chemistry

Substances

  • Antibodies, Monoclonal
  • HIV Envelope Protein gp41
  • Recombinant Fusion Proteins
  • Tryptophan
  • Leucine

Associated data

  • PDB/2CMR